ABCDEFGHIJKLMNOPQRSTUVWXYZAAABACADAEAF
1
For sources, see "Methods" sheet. Green shading indicates survey figures for which school-age children were the primary respondents.
2
By district
3
CountryGeographic areaPraziquantel coverage, from surveyPraziquantel reported coverageAlbendazole or mebendazole coverage, from surveyAlbendazole or mebendazole reported coverageIvermectin coverage, from surveyAdjustment factor for reported praziquantel treatmentsAdjustment factor for reported ALB/MEB treatments
4
Country A (2016)Location 1 (local location 1)59.8%28%38.2%17%39.3%214%225%
5
Location 1 (local location 2)56.7%43%61.9%66%64.9%132%94%
6
Location 2 (local location 1)67.7%24.6%61.9%77%63.7%275%80%
7
Location 2 (local location 2)44.4%26.1%60.2%82%64.6%170%73%
8
Location 3 (local location 1)N/AN/A0.9%42.0%94.51%71%41.7%N/A1%59%
9
Location 3 (local location 2)N/AN/A55.3%49.8%41.63%39%49.8%N/A133%128%
10
Location 3 (local location 3)N/AN/A42.5%45.0%75.21%63%45.0%N/A57%71%
11
Location 3 (local location 4)N/AN/A66.1%79%66.2%N/A84%
12
Location 4 (local location 1)95%19.26%66%59%66%493%112%
13
Location 4 (local location 2)95%23.98%65%84%65%396%77%
14
DRC (2016)Kasongo StateN/AN/A86%N/A86%N/AN/A
15
Chad (2017)The 7 regions targeted in the MDA87.0%93%90.5%81.6%95%82%82%93%96%99%
16
Angola (2017)Kwanza Sul (Kibala)48.1%43%47.4%43%N/A112%110%
17
Kwanza Sul (Libolo)64.8%43%64.4%43%N/A151%150%
18
Republic of Congo (2017)
PoolN/AN/A100.0%64.4%N/AN/A155%
19
PlateauxN/AN/A94.7%82.5%N/AN/A115%
20
Bouenza61.3%N/A91.2%63.6%N/AN/A143%
21
Lékoumou68.5%N/A100.0%66.3%N/AN/A151%
22
SanghaN/AN/A94.4%79.9%N/AN/A118%
23
LikoualaN/AN/A85.3%70.8%N/AN/A120%
24
Kouilou69.6%N/A100.0%69.6%N/AN/A144%
25
Pointe-NoireN/AN/A84.0%114.7%N/AN/A73%
26
BrazzavilleN/AN/A87.5%63.0%N/AN/A139%
27
28
Overall median66%49%66%65%
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100